College of Life Sciences, Northwest University, Xi'an 710069, China.
College of Life Sciences, Northwest University, Xi'an 710069, China.
J Pharm Biomed Anal. 2022 Oct 25;220:115022. doi: 10.1016/j.jpba.2022.115022. Epub 2022 Aug 29.
As expressed predominantly in cardiac tissue, beta1-adrenoceptor (β-AR) is broadly accepted as one of the main targets for drugs against cardiovascular ailments. However, the discovery of β-AR ligand is gravely challenged due to the lack of efficient screening method. This work developed a general strategy for pursuing β-AR ligands from the herbal extract by immobilizing haloalkane dehalogenase (Halo)-tagged β-AR onto microspheres coated with 6-chlorohexanoic acid, and applying the immobilized β-AR in the analysis of ligand-receptor interaction. The morphology was characterized by scanning electron microscope (SEM) and X-ray photoelectron spectroscopy (XPS). The chromatographic specificity of the immobilized receptor column was evaluated by determining the association constants of atenolol, esmolol and metoprolol using stepwise frontal analysis plus injection amount-dependent method. The potential ligands binding to β-AR was screened by collecting the peak with retention time longer than the void time, and identified the collection by reverse phase liquid chromatography coupled with tandem mass spectrometry. The association constants of the three drugs to β-AR were (3.33 ± 0.29)× 10 M, (2.33 ± 0.23)× 10 M and (2.06 ± 0.03)× 10 M, indicating a desired specificity of the immobilized receptor for recognizing its ligands. Molecular docking showed that van der Waals, hydrogen bonds, and hydrophobic interactions were the principal interaction forces for the receptor-drug complexes. Benzoylmesaconine was screened as the potential ligand of β-AR in Radix Aconiti Lateralis Praeparata extract. The association constant of the ligand was (1.06 ± 0.02)× 10 M, hinting structural modification may be required before clinical application. The immobilized β-AR is possible to provide a rapid method for screening potential ligands in herbal extract.
β1-肾上腺素能受体(β-AR)主要表达于心脏组织,被广泛认为是治疗心血管疾病药物的主要靶标之一。然而,由于缺乏有效的筛选方法,β-AR 配体的发现受到了严重的挑战。本工作通过将带有卤代烷脱卤酶(Halo)标签的β-AR 固定在涂有 6-氯己酸的微球上,开发了一种从草药提取物中寻找β-AR 配体的通用策略,并将固定化的β-AR 应用于配体-受体相互作用的分析。通过扫描电子显微镜(SEM)和 X 射线光电子能谱(XPS)对其形貌进行了表征。通过逐步前沿分析加进样量依赖法,测定阿替洛尔、艾司洛尔和美托洛尔的结合常数,评价了固定化受体柱的色谱特异性。通过收集保留时间长于空白时间的峰,筛选出与β-AR 结合的潜在配体,并通过反相液相色谱串联质谱进行鉴定。三种药物与β-AR 的结合常数分别为(3.33±0.29)×10 M、(2.33±0.23)×10 M 和(2.06±0.03)×10 M,表明固定化受体对其配体具有良好的特异性。分子对接表明,范德华力、氢键和疏水相互作用是受体-药物复合物的主要相互作用力。从乌头碱中筛选出苯甲酰乌头原碱作为β-AR 的潜在配体。配体的结合常数为(1.06±0.02)×10 M,提示在临床应用前可能需要进行结构修饰。固定化β-AR 可能为从草药提取物中筛选潜在配体提供一种快速方法。